Your Immune System Is Attacking You. Your Genes May Explain Why.

HLA-DQ2 is a protein on the surface of your immune cells that acts like a molecular display case. It presents fragments of foreign proteins (from bacteria, viruses, or your own tissues) to T-cells, essentially saying, “Is this one of us or an intruder?” If your T-cells are trained correctly, they recognize dangerous invaders and leave your own cells alone. It’s the primary gatekeeper between immune tolerance and autoimmune attack.

The HLA-DQ2 variant is present in roughly 25-30% of people with European ancestry. In isolation, carrying HLA-DQ2 doesn’t guarantee autoimmune disease. But it is required for certain autoimmune conditions to develop, most notably celiac disease, and strongly predisposes you to type 1 diabetes, rheumatoid arthritis, and other systemic conditions. Your antigen presentation system is essentially running a flawed training program for T-cells.

The lived experience is often invisible at first. You might have a strong reaction to a food, infection, or environmental trigger that others tolerate easily. Over time, your immune system develops a longer and longer list of things it sees as threatening. Your body becomes increasingly reactive. Food sensitivities expand. Seasonal allergies intensify. Eventually, the targeting shifts inward toward your own tissues. By then, the immune dysregulation is profound.

CTLA4 is a protein on the surface of T-cells that functions as an off switch. When CTLA4 engages with its partner molecule, it tells the T-cell, “Stop. Stand down. You’ve done enough.” Without this signal, T-cells continue attacking indefinitely. It is arguably the single most important genetic control point for preventing autoimmune disease.

The +49A>G variant, carried by roughly 45% of the population, reduces CTLA4 function, which means your T-cells don’t receive the shutdown signal as efficiently. With this variant, your immune cells remain more active longer, which dramatically increases your risk of multiple autoimmune conditions including Graves’ disease, celiac disease, lupus, and rheumatoid arthritis. Your emergency brake is weaker.

This shows up as an immune system that doesn’t know when to stop fighting. You develop an infection and recover, but your immune response persists. You eat a food that mildly triggers you, and your body remains inflamed for days. You experience stress, and your inflammatory markers stay elevated long after the stressor is gone. Your immune system has become hair-trigger reactive and slow to reset.

TNF-alpha is one of your body’s most powerful inflammatory signals. When you have an infection or injury, immune cells release TNF-alpha to alert the rest of your immune system and increase blood flow to the affected area. In short bursts, this is protective. Sustained, it becomes destructive. TNF is how your body says, “Everything in this region needs to change, now.”

The -308G>A variant, carried by roughly 30% of people with European ancestry, increases baseline TNF-alpha production. People with this variant produce more TNF-alpha in response to the same trigger, which means their inflammatory response amplifies faster and reaches higher levels than it should. Your inflammation dial is turned up.

You feel this as disproportionate responses to minor triggers. A small infection produces severe symptoms. A joint injury causes prolonged swelling and pain. Stress triggers immediate muscle tension and joint aching. Certain foods produce dramatic inflammatory reactions. Your body is essentially overreacting to standard challenges. Fatigue is common because inflammatory signaling consumes enormous amounts of energy. Brain fog accompanies the inflammation because TNF-alpha crosses the blood-brain barrier and drives neuroinflammation.

IL-6 is an inflammatory cytokine that amplifies the inflammation TNF-alpha started. TNF-alpha is the alarm bell. IL-6 is the signal that spreads throughout the body saying, “Everyone join in.” IL-6 also drives fever, sickness behavior (fatigue, pain, social withdrawal), and neuroinflammation. It’s one of the key bridges between peripheral inflammation and brain-based symptoms.

The -174G>C variant, present in roughly 40% of the population, increases IL-6 production in response to inflammatory triggers. People carrying the C allele produce more IL-6 in response to the same immune stimulus, which means inflammation not only starts faster but spreads more widely and lasts longer. Your inflammatory cascade is hyperactive.

You experience this as widespread, persistent inflammation rather than localized response. If you have an infection, your entire body feels sick, not just the infected area. If you have autoimmune activation, it doesn’t stay in one joint or one organ; it spreads. Neuroinflammation is common, showing up as brain fog, difficulty concentrating, depression, or anxiety that correlates with inflammatory flares. Fatigue is often severe because IL-6 is one of the primary drivers of systemic sickness response.

PTPN22 encodes a protein tyrosine phosphatase that helps regulate T-cell signaling. Think of it as a volume knob on immune activation. Too quiet and infections slip through. Too loud and the immune system attacks your own tissues. PTPN22 is responsible for fine-tuning that volume in response to what your T-cells encounter. It’s part of the learning mechanism that teaches your immune system the difference between self and non-self.

The 1858C>T variant, present in roughly 5-10% of European ancestry populations but significantly more common in people with autoimmune disease, impairs PTPN22 function. With this variant, your immune system becomes more reactive to self-antigens because the fine-tuning mechanism is broken; T-cells receive slightly different signaling, which reduces tolerance and increases autoimmune risk across multiple conditions. Your immune learning system has a defect.

This manifests as an immune system that seems to recognize more and more things as threatening. You develop food sensitivities that didn’t exist before. Seasonal allergies intensify. Cross-reactivity becomes common, where your immune system attacks your own tissues because they resemble pathogens. The activation threshold lowers progressively. You become increasingly sensitive to environmental triggers: molds, dust, pollen, chemicals.

IRF5 is a transcription factor that controls whether immune cells choose the pro-inflammatory or anti-inflammatory pathway. When IRF5 is active, immune cells produce more inflammatory cytokines and become more aggressive. It’s essentially a master switch that says, “Be aggressive” rather than “Be measured.” IRF5 activity determines whether your immune response is balanced or skewed toward attack.

The IRF5 variants associated with autoimmune risk increase IRF5 expression and activity. People carrying risk alleles have immune cells that more readily choose the aggressive pro-inflammatory pathway in response to triggers. This means your macrophages and dendritic cells are biased toward producing TNF-alpha, IL-6, and IL-1B, which amplifies the entire inflammatory cascade and predisposes you to both systemic and organ-specific autoimmune conditions. Your immune cells have a default setting toward aggression.

You feel this as an immune system in perpetual combat mode. Minor infections trigger severe responses. Stress immediately activates immune aggression. Your baseline inflammatory markers are elevated even in periods of relative wellness. You develop multiple autoimmune symptoms simultaneously rather than one condition at a time. The inflammation feels pervasive rather than localized. Recovery from illness is slow because your immune system remains activated long after the pathogen is gone.